These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16122919)

  • 21. Quality of spirometry in primary care for case finding of airway obstruction in smokers.
    Leuppi JD; Miedinger D; Chhajed PN; Buess C; Schafroth S; Bucher HC; Tamm M
    Respiration; 2010; 79(6):469-74. PubMed ID: 19786731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic obstructive pulmonary disease case finding in Mexico in an at-risk population.
    Laniado-Laborin R; Rendón A; Bauerle O
    Int J Tuberc Lung Dis; 2011 Jun; 15(6):818-23. PubMed ID: 21575305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Six-second spirometry for detection of airway obstruction: a population-based study in Austria.
    Lamprecht B; Schirnhofer L; Tiefenbacher F; Kaiser B; Buist SA; Studnicka M; Enright P
    Am J Respir Crit Care Med; 2007 Sep; 176(5):460-4. PubMed ID: 17556719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of atopy, asthma and COPD in an urban and a rural area of an African country.
    Musafiri S; van Meerbeeck J; Musango L; Brusselle G; Joos G; Seminega B; Rutayisire C
    Respir Med; 2011 Nov; 105(11):1596-605. PubMed ID: 21783353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over.
    Tinkelman DG; Price DB; Nordyke RJ; Halbert RJ
    J Asthma; 2006; 43(1):75-80. PubMed ID: 16448970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measuring FEV(6) for detecting early airway obstruction in the primary care setting. Quality and utility of the new PiKo-6 device.
    Kaufmann M; Hartl S; Geyer K; Breyer MK; Burghuber OC
    Respiration; 2009; 78(2):161-7. PubMed ID: 19174602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nasal symptoms, airway obstruction and disease severity in chronic obstructive pulmonary disease.
    Hurst JR; Kuchai R; Michael P; Perera WR; Wilkinson TM; Wedzicha JA
    Clin Physiol Funct Imaging; 2006 Jul; 26(4):251-6. PubMed ID: 16836700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Restrictive pattern in spirometry: does FEV(1)/FVC need to be increased?].
    Wesołowski S; Boros P
    Pneumonol Alergol Pol; 2011; 79(6):382-7. PubMed ID: 22028116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breathlessness and skeletal muscle weakness in patients undergoing lung health screening in primary care.
    Kelly JL; Elkin SL; Fluxman J; Polkey MI; Soljak MA; Hopkinson NS
    COPD; 2013 Feb; 10(1):40-54. PubMed ID: 23272667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers.
    Miravitlles M; Ferrer M; Pont A; Luis Viejo J; Fernando Masa J; Gabriel R; Jiménez-Ruiz CA; Villasante C; Fernández-Fau L; Sobradillo V
    Respir Med; 2005 Aug; 99(8):985-95. PubMed ID: 15950139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Airway obstruction in relation to symptoms in chronic respiratory disease--a nationally representative population study.
    von Hertzen L; Reunanen A; Impivaara O; Mälkiä E; Aromaa A
    Respir Med; 2000 Apr; 94(4):356-63. PubMed ID: 10845434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and predictors of undiagnosed chronic obstructive pulmonary disease in a Norwegian adult general population.
    Hvidsten SC; Storesund L; Wentzel-Larsen T; Gulsvik A; Lehmann S
    Clin Respir J; 2010 Jan; 4(1):13-21. PubMed ID: 20298413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review.
    Mohamed Hoesein FA; Zanen P; Lammers JW
    Respir Med; 2011 Jun; 105(6):907-15. PubMed ID: 21295958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting inadequate spirometry technique and the use of FEV1/FEV3 as an alternative to FEV1/FVC for patients with mild cognitive impairment.
    Allen S; Yeung P; Janczewski M; Siddique N
    Clin Respir J; 2008 Oct; 2(4):208-13. PubMed ID: 20298336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies for screening for chronic obstructive pulmonary disease.
    Enright PL; Kaminsky DA
    Respir Care; 2003 Dec; 48(12):1194-201; discussion 1201-3. PubMed ID: 14651760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Undiagnosed airflow limitation in patients at cardiovascular risk.
    Bérard E; Bongard V; Roche N; Perez T; Brouquières D; Taraszkiewicz D; Fievez S; Denis F; Escamilla R; Ferrières J
    Arch Cardiovasc Dis; 2011 Dec; 104(12):619-26. PubMed ID: 22152514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of respiratory symptom development in patients with chronic airflow obstruction.
    Chang JH; Lee JH; Kim MK; Kim SJ; Kim KH; Park JS; Kim TH; Kim YI; Lee EW; Kim JO; Hong SB; Kim DS
    Respir Med; 2006 Dec; 100(12):2170-6. PubMed ID: 16675214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of obstructive respiratory disorders in the rural population of the Lublin region.
    Paprzycki P; Panasiuk L; Sodolski W
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):72-8. PubMed ID: 15314962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender and chronic obstructive pulmonary disease in high-risk smokers.
    de Torres JP; Campo A; Casanova C; Aguirre-Jaime A; Zulueta J
    Respiration; 2006; 73(3):306-10. PubMed ID: 16330871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The health impact of undiagnosed airflow obstruction in a national sample of United States adults.
    Coultas DB; Mapel D; Gagnon R; Lydick E
    Am J Respir Crit Care Med; 2001 Aug; 164(3):372-7. PubMed ID: 11500335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.